Lenalidomide also inhibits MALT1-mediated BCL10 cleavage and suppresses NFκB activity in non-GCB DLBCL cell lines (22); however, the involvement of CK1α in these activities has not been investigated. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.